Recent advances in the management of Hodgkin lymphoma

4Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

Hodgkin lymphoma (HL) is a rare cancer of the immune system that typically affects lymph nodes and sometimes other organs. Although the majority of patients can be potentially cured with the use of multi-agent chemotherapy and radiotherapy, a proportion of them will relapse or develop resistant disease for which treatment options are limited. In recent years, new agents have been developed and tested in HL with encouraging results. Two classes of drugs stand out as highly active in advanced HL based on recent study results: antibody-drug conjugates and programmed death 1 inhibitors. Clinical trials in HL with these agents have been completed in the past several years and the results have recently become available. In this review, we discuss the recent advances in the management of HL with a focus on strategies to decrease toxicity and a review of the two drug classes that have the potential to change the landscape of treatment of this disease.

References Powered by Scopus

Cancer statistics, 2016

23615Citations
N/AReaders
Get full text

Chimeric antigen receptor T cells for sustained remissions in leukemia

4444Citations
N/AReaders
Get full text

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

3045Citations
N/AReaders
Get full text

Cited by Powered by Scopus

High Serum Level of Soluble Programmed Death Ligand 1 is Associated With a Poor Prognosis in Hodgkin Lymphoma

27Citations
N/AReaders
Get full text

Diagnosis and treatment of patients with Hodgkin lymphoma

1Citations
N/AReaders
Get full text

Comparison and evaluation of different treatment plans with IFRT field and 6 and 18 mv energies in hodgkin’s lymphoma involvement neck and mediastinum

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Villasboas, J. C., & Ansell, S. M. (2016). Recent advances in the management of Hodgkin lymphoma. F1000Research. Faculty of 1000 Ltd. https://doi.org/10.12688/f1000research.8301.1

Readers over time

‘16‘17‘18‘19‘20‘21‘22036912

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 15

79%

Researcher 4

21%

Readers' Discipline

Tooltip

Medicine and Dentistry 12

57%

Biochemistry, Genetics and Molecular Bi... 5

24%

Immunology and Microbiology 3

14%

Materials Science 1

5%

Save time finding and organizing research with Mendeley

Sign up for free
0